S'abonner

Ultrasonography Versus Landmark for Peripheral Intravenous Cannulation: A Randomized Controlled Trial - 24/06/16

Doi : 10.1016/j.annemergmed.2015.09.009 
Melissa L. McCarthy, ScD a, b, , Hamid Shokoohi, MD, MPH b, Keith S. Boniface, MD, RDMS b, Russell Eggelton, EMT-B, EDT c, Andrew Lowey, BS, EMT-P c, Kelvin Lim, BS c, Robert Shesser, MD b, Ximin Li, MS d, Scott L. Zeger, PhD d
a Department of Health Policy and Management, George Washington University Hospital, Washington, DC 
b Department of Emergency Medicine, George Washington University Hospital, Washington, DC 
c George Washington University Hospital, Washington, DC 
d Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 

Corresponding Author.

Abstract

Study objective

Randomized controlled trials report inconsistent findings when comparing the initial success rate of peripheral intravenous cannulation using landmark versus ultrasonography for patients with difficult venous access. We sought to determine which method is superior for patients with varying levels of intravenous access difficulty.

Methods

We conducted a 2-group, parallel, randomized, controlled trial and randomly allocated 1,189 adult emergency department (ED) patients to landmark or ultrasonography, stratified by difficulty of access and operator. ED technicians performed the peripheral intravenous cannulations. Before randomization, technicians classified subjects as difficult, moderately difficult, or easy access according to visible or palpable veins and perception of difficulty with a landmark approach. If the first attempt failed, we randomized subjects a second time. We compared the initial and second-attempt success rates by procedural approach and difficulty of intravenous access, using a generalized linear mixed regression model, adjusted for operator.

Results

The 33 participating technicians enrolled a median of 26 subjects (interquartile range 9 to 55). The initial success rate was 81% but varied significantly by technique and difficulty of access. The initial success rate by ultrasonography was higher than landmark for patients with difficult access (48.0 more successes per 100 tries; 95% confidence interval [CI] 35.6 to 60.3) or moderately difficult access (10. 2 more successes per 100 tries; 95% CI 1.7 to 18.7). Among patients with easy access, landmark yielded a higher success rate (10.6 more successes per 100 tries; 95% CI 5.8 to 15.4). The pattern of second-attempt success rates was similar.

Conclusion

Ultrasonographic peripheral intravenous cannulation is advantageous among patients with difficult or moderately difficult intravenous access but is disadvantageous among patients anticipated to have easy access.

Le texte complet de cet article est disponible en PDF.

Plan


 Please see page 11 for the Editor’s Capsule Summary of this article.
 Supervising editor: Donald M. Yealy, MD
 Author contributions: MLM, HS, KSB, RE, and SLZ conceived the study and designed the trial. MLM and RS obtained research funding. MLM, HS, RE, AL, and KL supervised the conduct of the trial and data collection and undertook recruitment of patients. XL and SLZ provided statistical advice on study design and analyzed the data. MLM managed the data, including quality control, and drafted the article, and all authors contributed substantially to its revision. MLM takes responsibility for the paper as a whole.
 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org/). The authors have stated that no such relationships exist and provided the following details: This study was supported in part by award K01HS017957 from the Agency for Healthcare Research and Quality. For every 3 subjects enrolled, the authors gave the technician a $5 gift card as a token of appreciation for assisting with study enrollment and data collection in addition to his or her clinical responsibilities.
 Clinical trial registration number: NCT01859559
 The sponsor was not involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the article. The content is solely the responsibility of the authors and does not represent the official views of the Agency for Healthcare Research and Quality.
 A XHRWYPD survey is available with each research article published on the Web at www.annemergmed.com.
 A podcast for this article is available at www.annemergmed.com.


© 2015  American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 68 - N° 1

P. 10-18 - juillet 2016 Retour au numéro
Article précédent Article précédent
  • Isopropyl Alcohol Nasal Inhalation for Nausea in the Emergency Department: A Randomized Controlled Trial
  • Kenneth Lee Beadle, Antonia R. Helbling, Sue L. Love, Michael D. April, Curtis J. Hunter
| Article suivant Article suivant
  • Male With Pain in Right Calf
  • David C. Pigott, C. Blayke Gibson, Casey A. McIntosh, John P. Gullett

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.